Farah Babakhani

Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain

Laurica A Petrella, Susan P. Sambol, Adam Cheknis et al. · Clinical Infectious Diseases · 2012 · 183 citations · Full text

FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid

Elliot S. Friedman, Yun Li, Ting‐Chin David Shen et al. · Gastroenterology · 2018 · 135 citations

Dysbiosis, Medicine, Microbiota +11

Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection

Michelle M. Nerandzic, Kathleen M. Mullane, Mark A. Miller et al. · Clinical Infectious Diseases · 2012 · 130 citations · Full text

Fidaxomicin Inhibits Spore Production in Clostridium difficile

Farah Babakhani, Laurent Bouillaut, Abraham Gomez et al. · Clinical Infectious Diseases · 2012 · 123 citations · Full text

Antibacterial Agents, Bacteriology, Antimicrobial Chemotherapy +21

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

Ellie J. C. Goldstein, Diane M. Citron, P.S. Sears et al. · Antimicrobial Agents and Chemotherapy · 2011 · 106 citations · Full text